[{"indications": "Indications\u00a0dyspepsia; hyperphosphataemia (section 9.5.2.2)", "name": "ALUMINIUM HYDROXIDE Aluminium-only preparations", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.1 Dyspepsia and gastro-oesophageal reflux disease", "1.1.1 Antacids and simeticone", "Aluminium- and magnesium-containing antacids", "ALUMINIUM HYDROXIDE", "Aluminium-only preparations"], "cautions": "Cautions\u00a0\n(From 1.1.1 Antacids and simeticone: British National Formulary)\nAluminium- and magnesium-containing antacids (e.g. aluminium hydroxide, and magnesium carbonate, hydroxide and trisilicate), being relatively insoluble in water, are long-acting if retained in the stomach. They are suitable for most antacid purposes. Magnesium-containing antacids tend to be laxative whereas aluminium-containing antacids may be constipating; antacids containing both magnesium and aluminium may reduce these colonic side-effects. Aluminium accumulation does not appear to be a risk if renal function is normal.; interactions: Appendix 1 (antacids)", "side-effects": "Side-effects\u00a0see notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2021.htm", "doses": ["Name[Alu-Cap\u00ae (Meda)] Capsules, green/red, dried aluminium hydroxide 475\u00a0mg (low Na+). Net price\r\n120-cap pack = \u00a34.57Dose\u00a0antacid, 1 capsule 4 times daily and at bedtime; child not recommended for antacid therapy"]}, {"indications": "Indications\u00a0dyspepsia; hyperphosphataemia (section 9.5.2.2)", "name": "ALUMINIUM HYDROXIDE Co-magaldrox", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.1 Dyspepsia and gastro-oesophageal reflux disease", "1.1.1 Antacids and simeticone", "Aluminium- and magnesium-containing antacids", "ALUMINIUM HYDROXIDE", "Co-magaldrox"], "cautions": "Cautions\u00a0\n(From 1.1.1 Antacids and simeticone: British National Formulary)\nAluminium- and magnesium-containing antacids (e.g. aluminium hydroxide, and magnesium carbonate, hydroxide and trisilicate), being relatively insoluble in water, are long-acting if retained in the stomach. They are suitable for most antacid purposes. Magnesium-containing antacids tend to be laxative whereas aluminium-containing antacids may be constipating; antacids containing both magnesium and aluminium may reduce these colonic side-effects. Aluminium accumulation does not appear to be a risk if renal function is normal.; interactions: Appendix 1 (antacids)", "side-effects": "Side-effects\u00a0see notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2025.htm", "doses": ["Name[Mucogel\u00ae (Chemidex)] Suspension, sugar-free, co-magaldrox\r\n195/220 (magnesium hydroxide 195\u00a0mg, dried aluminium hydroxide 220\u00a0mg/5\u00a0mL\r\n(low Na+)). Net price 500\u00a0mL = \u00a31.71Dose\u00a0adult and child over 12 years, 10\u201320\u00a0mL 3 times daily, 20\u201360\r\nminutes after meals, and at bedtime or when required"]}, {"indications": "Indications\u00a0hyperphosphataemia; dyspepsia (section 1.1)", "name": "ALUMINIUM HYDROXIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.5 Minerals", "9.5.2 Phosphorus", "9.5.2.2 Phosphate-binding agents", "ALUMINIUM HYDROXIDE"], "cautions": "Cautions\u00a0\n(From 9.5.2.2 Phosphate-binding agents: British National Formulary)\n9.5.2.2 Phosphate-binding agents; interactions: Appendix 1 (antacids)", "side-effects": "Side-effects\u00a0constipation; hyperaluminaemia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5065.htm", "doses": ["phosphate-binding agent in renal failure, 4\u201320 capsules\r\ndaily in divided doses with meals"]}]